The U.S. Department of Health and Human Services has announced a new pioneer accountable care organization model.
Updates on recent FDA approvals, appointments, acquisitions and alliances in the pharmaceutical industry.
The presence of albuminuria — too much albumin, or protein, in urine — detected by a urine test could be used as an independent predictor of cognitive decline.
The Centers for Disease Control and Prevention will award a total of $40 million in grants to all 58 U.S. states and territories for three-year coordinated chronic disease programs.
In a study in Australia, the HPV vaccine Gardasil helped to reduce the number of teenage girls who develop cervical abnormalities by as much as 50 percent.
A new approach developed that uses an adjuvant along with a vaccine shows that newborns may be able to be vaccinated and protected from disease.
Two new bipartisan bills have been introduced to safeguard the development of drugs and therapies for patients with rare diseases.
A retrospective analysis showed high-dose intravenous immunoglobulin may provide symptomatic relief in patients with sensorimotor neuropathy or nonataxic sensory neuropathy associated with primary Sjögren’s syndrome.
Researchers are seeing promising results in animals from a vaccine designed to prevent a heroin high.
Long-term prophylactic administration of Octapharma’s Wilate factor VIII/von Willebrand factor(VWF) concentrate dramatically reduced bleeding episodes in 24 patients with von Willebrand disease.
Final regulations published by the Equal Employment Opportunity Commission protect many more employees from disability discrimination in the workplace than had previously been the case.
Researchers at the Emory Vaccine Center at Emory University, Atlanta, Ga., have developed a method for predicting whether someone will produce high levels of antibodies against a flu shot a few days after vaccination.